STAT3 and breast carcinoma: Further, it has been explored that C15:0 has an inhibitory effect on the IL-6-induced JAK2/STAT3 signaling pathway in human breast carcinoma cells, considering C15:0 as a promising therapeutic strategy to treat human cancers [17,18].